Royalty Keeps Pushing $6.6B Buyout Despite Elan's Refusal

By Karlee Weinmann (March 6, 2013, 1:23 PM EST) -- New York investment firm Royalty Pharma LLC on Wednesday reaffirmed its spurned $6.6 billion takeover offer for Irish life sciences firm Elan Corp., saying it had planned talks with several of its target's biggest shareholders in an effort to sell them on the bid....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!